BL
RVMD icon

Bleichroeder LP’s Revolution Medicines RVMD Stock Holding History

Bleichroeder LP’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-556
Closed -$54.1K – 86
2026
Q1 		$54.1K Hold
556
– – 0.01% 69
2025
Q4 		$44.3K Hold
556
– – 0.01% 67
2025
Q3 		$26K Hold
556
– – 0.01% 66
2025
Q2 		$20.5K Hold
556
– – 0.01% 69
2025
Q1 		$19.7K Hold
556
– – 0.01% 71
2024
Q4 		$24.3K Hold
556
– – 0.01% 68
2024
Q3 		$25.2K Hold
556
– – 0.01% 66
2024
Q2 		$21.6K Hold
556
– – 0.01% 66
2024
Q1 		$17.9K Hold
556
– – ﹤0.01% 73
2023
Q4 		$15.9K Buy
+556
New +$13.4K ﹤0.01% 67

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bleichroeder LP's RVMD Position: Q2 2026 in Review

Bleichroeder LP sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 556 shares — an estimated $54.1K sold.

Bleichroeder LP first reported a position in RVMD in Q4 2023 and held it in 10 quarters. The position peaked at $54.1K in Q1 2026. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bleichroeder LP reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Bleichroeder LP sold 556 Revolution Medicines shares in Q2 2026, an estimated $54.1K.
  • Bleichroeder LP first reported a position in Revolution Medicines in Q4 2023 and held it in 10 quarters.
  • Bleichroeder LP's Revolution Medicines position peaked at $54.1K in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.